Regulating Nanomedicine: A European Perspective

Posted: 28 Feb 2012 Last revised: 22 Feb 2014

Date Written: October 18, 2008

Abstract

The potential impact of nanomedicine is foreseen to radically change health care; however it also challenges existing perceptions, dynamics and standards relating to ethics, safety and governance. This commentary briefly highlights aspects and approaches pertaining to nanomedical regulation in the European Union.

Keywords: Nanotechnology, nanomedicine, regulation, technologies, Law

JEL Classification: K32

Suggested Citation

D'Silva, Joel and van Calster, Geert, Regulating Nanomedicine: A European Perspective (October 18, 2008). Available at SSRN: https://ssrn.com/abstract=1286215 or http://dx.doi.org/10.2139/ssrn.1286215

Joel D'Silva (Contact Author)

Legal Researcher ( email )

Leuven, 3000
Belgium

Geert Van Calster

K.U. Leuven ( email )

Tiensestraat 41
Bus 3424
B-3000 Leuven, 3000
Belgium

HOME PAGE: http://www.gavc.be

Register to save articles to
your library

Register

Paper statistics

Abstract Views
792
PlumX Metrics